DAVID M. STACK - 06 Jun 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
CEO and Chairman, Director
Signature
/s/ Kristen Williams, Attorney-in-Fact
Issuer symbol
PCRX
Transactions as of
06 Jun 2023
Net transactions value
-$398,885
Form type
4
Filing time
07 Jun 2023, 21:33:34 UTC
Previous filing
08 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale $197,216 -5,058 -3.1% $38.99 159,107 06 Jun 2023 Direct F1, F2
transaction PCRX Common Stock Sale $201,669 -5,326 -3.3% $37.86 153,781 07 Jun 2023 Direct F1
holding PCRX Common Stock 97,273 06 Jun 2023 By Three Colleens Investment, LLC F3
holding PCRX Common Stock 18,596 06 Jun 2023 By Stack Schroon Mohawk FLP F3
holding PCRX Common Stock 315 06 Jun 2023 LCK Investment LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes an aggregate of 414 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022 and December 2022.
F3 Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.